Pharmacokinetics and Safety of Ertapenem in the Postpartum Period
NCT01587495
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class
Stopped
study terminated due to low subject accrual
Conditions
Endometritis
Interventions
DRUG:
Ertapenem
Sponsor
Daniel Benjamin